Agilent Technologies - A Stock Forecast, Price & News

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" A shares.
View A analyst ratings or view top-rated stocks.

13 analysts have issued 12 month price targets for Agilent Technologies' shares. Their A share price forecasts range from $140.00 to $170.00. On average, they expect the company's share price to reach $161.36 in the next year. This suggests a possible upside of 3.3% from the stock's current price.
View analysts price targets for A or view top-rated stocks among Wall Street analysts.

Agilent Technologies' stock was trading at $149.65 at the beginning of the year. Since then, A stock has increased by 4.4% and is now trading at $156.23.
View the best growth stocks for 2023 here.

Agilent Technologies saw a increase in short interest during the month of December. As of December 30th, there was short interest totaling 3,270,000 shares, an increase of 5.5% from the December 15th total of 3,100,000 shares. Based on an average daily volume of 1,340,000 shares, the days-to-cover ratio is currently 2.4 days. Approximately 1.1% of the company's shares are short sold.
View Agilent Technologies' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023.
View our A earnings forecast.

Agilent Technologies, Inc. (NYSE:A) released its quarterly earnings results on Monday, November, 21st. The medical research company reported $1.53 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.14. The medical research company had revenue of $1.85 billion for the quarter, compared to the consensus estimate of $1.76 billion. Agilent Technologies had a trailing twelve-month return on equity of 30.28% and a net margin of 18.31%. The company's revenue was up 11.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.21 earnings per share.
Read the conference call transcript.

Agilent Technologies announced a quarterly dividend on Wednesday, November 16th. Stockholders of record on Tuesday, January 3rd will be given a dividend of $0.225 per share on Wednesday, January 25th. This represents a $0.90 dividend on an annualized basis and a yield of 0.58%. The ex-dividend date of this dividend is Friday, December 30th. This is a boost from the stock's previous quarterly dividend of $0.21.
Read our dividend analysis for A.

Agilent Technologies (NYSE:A) pays an annual dividend of $0.90 per share and currently has a dividend yield of 0.58%. The company has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 21.58%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, A will have a dividend payout ratio of 14.52% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for A.

Agilent Technologies declared that its board has approved a stock repurchase program on Monday, January 9th 2023, which allows the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy up to 4.4% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's board believes its shares are undervalued.

Agilent Technologies issued an update on its first quarter 2023 earnings guidance on Wednesday, December, 21st. The company provided earnings per share guidance of $1.29-$1.31 for the period, compared to the consensus EPS estimate of $1.31. The company issued revenue guidance of $1.68 billion-$1.70 billion, compared to the consensus revenue estimate of $1.73 billion.

452 employees have rated Agilent Technologies Chief Executive Officer Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among the company's employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Agilent Technologies' stock is owned by a number of retail and institutional investors. Top institutional investors include LGT Capital Partners LTD. (0.45%), Troy Asset Management Ltd (0.32%), Pendal Group Ltd (0.24%), Allspring Global Investments Holdings LLC (0.19%), Ardevora Asset Management LLP (0.16%) and Scout Investments Inc. (0.16%). Insiders that own company stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Henrik Ancher-Jensen, Jacob Thaysen, Mark Doak, Michael R Mcmullen, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Rodney Gonsalves and Samraat S Raha.
View institutional ownership trends.

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of A stock can currently be purchased for approximately $156.23.

Agilent Technologies (NYSE:A) has a market capitalization of $46.26 billion and generates $6.85 billion in revenue each year. The medical research company earns $1.25 billion in net income (profit) each year or $4.17 on an earnings per share basis.

The company employs 18,100 workers across the globe.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The official website for the company is www.agilent.com. The medical research company can be reached via phone at (800) 227-9770, via email at investor_relations@agilent.com, or via fax at 408-345-8474.